POC immunoassay for hCG
A publication in Clinical Chemistry entitled, “Quantitative, Wide-Range, 5-Minute Point of-Care Immunoassay for Total Human Chorionic Gonadotropin in Whole Blood” by Piia von Lode et al uses Meridian Life Science, Inc. (MLS) # MAF05-043, monoclonal antibody to beta hCG, clone # 057-10043 (OEM Concepts brand) in the development of a POC immunoassay for hCG. This antibody is specific for intact-hCG and its beta subunit. It does not cross react with hCG alpha subunit.
The authors’ achieved their goal of developing a simple and rapid POC assay that relied on noncompetitive assay techniques similar to those in immunoassays used for routine laboratory testing. In addition, their POC assay reacted with hyperglycosylated hCG, nicked hCG, free hCGß, nicked free hCGß and hCGß core fragment.
Most read news
Other news from the department manufacturing
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous